{"id":5175,"date":"2026-03-26T09:25:44","date_gmt":"2026-03-25T23:25:44","guid":{"rendered":"\/americas\/?p=5175"},"modified":"2026-03-26T09:25:44","modified_gmt":"2026-03-25T23:25:44","slug":"the-armchair-analyst-what-makes-a-surgeon-adopt-a-product","status":"publish","type":"post","link":"\/americas\/the-armchair-analyst-what-makes-a-surgeon-adopt-a-product\/","title":{"rendered":"The Armchair Analyst | What makes a surgeon adopt a product?"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text css=””]Surgeon adoption is a key factor in the commercialisation of medical technologies.\u00a0But what influences whether a surgeon chooses to adopt a new product in clinical practice?<\/span><\/p>\n

A recent article\u00a0published\u00a0in\u00a0The Armchair Analyst\u00a0explores this question through the real-world reflections of an experienced surgeon, \u201cSurgeon Dan,\u201d using\u00a0Orthocell\u2019s\u00a0\u00a0\u00a0nerve repair product,\u00a0Remplir\u2122\u00a0for\u00a0Nerve-sparing Robotic Assisted Radical Prostatectomy (NS-RARP).<\/span>\u00a0<\/span><\/p>\n

Below is an excerpt, in Surgeon Dan\u2019s own words:<\/span>\u00a0<\/span><\/p>\n

\u201c<\/i>Getting surgeons to switch products can be hard.<\/i><\/strong><\/span><\/h4>\n

We get used to doing procedures in our own way, with our own product set.
\n<\/i><\/i><\/span><\/h4>\n

So new products that come to market, looking to displace existing products, can\u2019t just be equivalent.<\/i><\/span><\/h4>\n

They need to be markedly better for a surgeon to make the switch.<\/i><\/span><\/h4>\n

Alternatively, if there is a\u00a0<\/i><\/span>true unmet need<\/i><\/strong><\/span>, then adopting those products is a much easier decision.<\/i><\/span><\/span><\/h4>\n

That is what I saw when two\u00a0<\/i>Orthocell\u00a0(ASX: OCC)\u00a0<\/i>reps came into my practice three weeks ago to demonstrate\u00a0Remplir\u2019s\u00a0ability to\u00a0<\/i><\/span>restore erectile nerve function for men who have had prostate cancer<\/span>.<\/i><\/strong><\/span><\/h4>\n

Because this is a true unmet need.<\/span>“<\/span><\/i><\/span><\/h4>\n

<\/h4>\n

This perspective highlights the practical realities of surgeon decision-making\u00a0\u2013\u00a0where\u00a0familiarity, workflow and demonstrable benefit\u00a0ultimately determine\u00a0whether a product is adopted in practice.<\/span>\u00a0<\/span><\/p>\n

Read the full article<\/span><\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Surgeon adoption is a key factor in the commercialisation of medical technologies. But what influences whether a surgeon chooses to adopt a new product in clinical practice?<\/p>\n","protected":false},"author":2,"featured_media":5176,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-video"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t